210 related articles for article (PubMed ID: 954013)
1. Randomized prospective trial comparing 5-fluorouracil (NSC-19893) to 5-fluorouracil and methyl-CCNU (NSC-95441) in advanced gastrointestinal cancer.
Baker LH; Vaitkevicius VK; Gehan E
Cancer Treat Rep; 1976 Jun; 60(6):733-7. PubMed ID: 954013
[TBL] [Abstract][Full Text] [Related]
2. A controlled study of 5-fluorouracil versus 5-fluorouracil and methyl-CCNU in advanced gastrointestinal adenocarcinoma.
Abdallah AM; Soukop M; Bell G; Calman KC
Clin Oncol; 1977 Sep; 3(3):247-57. PubMed ID: 334430
[No Abstract] [Full Text] [Related]
3. Nitrosoureas: useful agents for the treatment of advanced gastrointestinal cancer.
Douglass HO; Lavin PT; Moertel CG
Cancer Treat Rep; 1976 Jun; 60(6):769-80. PubMed ID: 782699
[TBL] [Abstract][Full Text] [Related]
4. [Treatment of advanced digestive cancer with fluorouracil and methyl-CCNU].
Fleischer I; Wainstein R; Jovtis S; Colombato LO
Acta Gastroenterol Latinoam; 1978; 8(3):191-3. PubMed ID: 747086
[TBL] [Abstract][Full Text] [Related]
5. Phase I trial of ftorafur combined with mitomycin C or methyl-CCNU in gastrointestinal cancers.
Buroker T; Baker L; Correa J; Schwartz LA; Vailtkevicius VK
Cancer Treat Rep; 1977; 61(3):463-7. PubMed ID: 326403
[TBL] [Abstract][Full Text] [Related]
6. 5-Fluorouracil (5-FU), methyl-CCNU, and vincristine in the treatment of advanced colorectal cancer: phase II study utilizing weekly 5-FU.
Macdonald JS; Kisner DF; Smythe T; Woolley PV; Smith L; Schein PS
Cancer Treat Rep; 1976 Nov; 60(11):1597-600. PubMed ID: 1021233
[TBL] [Abstract][Full Text] [Related]
7. Randomized trial of melphalan plus 5-fluorouracil (5-FU) versus methyl-CCNU plus 5-FU in patients with advanced colorectal cancer.
Berman R; Giles GR; Malhotra A; Bird GG; Gajjar PD; Bunch GA; Hall R
Cancer Treat Rep; 1978 Mar; 62(3):457-9. PubMed ID: 348316
[No Abstract] [Full Text] [Related]
8. Phase III comparison of the treatment of advanced gastrointestinal cancer with bolus weekly 5-FU vs. methyl-CCNU plus bolus weekly 5-FU. A Southwest Oncology Group study.
Baker LH; Talley RW; Matter R; Lehane DE; Ruffner BW; Jones SE; Morrison FS; Stephens RL; Gehan EA; Vaitkevicius VK
Cancer; 1976 Jul; 38(1):1-7. PubMed ID: 779949
[TBL] [Abstract][Full Text] [Related]
9. Phase II trial of ftorafur with mitomycin C versus ftorafur with methyl-CCNU in untreated colorectal cancer.
Buroker T; Wojtaszak B; Dindogru A; DeMattia M; Baker L; Groth C; Vaitkevicius VK
Cancer Treat Rep; 1978 May; 62(5):689-92. PubMed ID: 350398
[TBL] [Abstract][Full Text] [Related]
10. Methyl-CCNU (NSCU-95441) versus methyl-CCNU plus cyclophosphamide (NSC-26271) in advanced gastrointestinal cancer.
Rossi A; Riva A; Bonadonna G
Cancer Chemother Rep; 1975; 59(6):1161-2. PubMed ID: 769958
[No Abstract] [Full Text] [Related]
11. Methyl-CCNU (NSC-95441) in advanced colorectal carcinoma after failure of 5-fluorouracil (NSC-19893) therapy.
Cedermark BJ; Didolkar MS; Elias EG
Cancer Treat Rep; 1976 Mar; 60(3):235-8. PubMed ID: 769977
[TBL] [Abstract][Full Text] [Related]
12. Methyl-CCNU versus methyl-CCNU and 5-fluorouracil in carcinoma of the large bowel.
Posey LE; Morgan LR
Cancer Treat Rep; 1977 Nov; 61(8):1453-8. PubMed ID: 922750
[TBL] [Abstract][Full Text] [Related]
13. Phase II study of 5-fluorouracil, methyl-CCNU, and daunorubicin in colorectal cancer: a Cancer and Leukemia Group B study.
White LA; Perry MC; Kardinal CG; Kennedy BJ; Weiss RB; Carey RW
Cancer Treat Rep; 1979 Feb; 63(2):215-7. PubMed ID: 445497
[TBL] [Abstract][Full Text] [Related]
14. [The combination methyl-CCNU, vincristine, 5-fluorouracil and streptozotocin in the treatment of advanced colo-rectal adenocarcinoma].
Togni P; Sessa C; Varini M; Cavalli F
Schweiz Med Wochenschr; 1982 Jun; 112(26):930-3. PubMed ID: 6214002
[TBL] [Abstract][Full Text] [Related]
15. Multi-drug chemotherapy with and without radiation for carcinoma of the stomach and pancreas: a prospective randomized trial.
Hazel JJ; Thirlwell MP; Huggins M; Maksymiuk A; MacFarlane JK
J Can Assoc Radiol; 1981 Sep; 32(3):164-5. PubMed ID: 7028759
[TBL] [Abstract][Full Text] [Related]
16. Combination with 5-fluorouracil, methyl-CCNU and beta-2-deoxythioguanosine in advanced colo-rectal adenocarcinoma.
Cedermark BJ; Kaufman JH; Douglass HO; Mittelman A
Clin Oncol; 1977 Mar; 3(1):27-31. PubMed ID: 862274
[No Abstract] [Full Text] [Related]
17. Combination chemotherapy with 5-fluorouracil and methyl-CCNU for the treatment of advanced gastrointestinal cancer.
Brutti A; Liberati AM; Biscottini B; Fatati G; Sini S; Barzi AM; Grignani F
Tumori; 1979 Jun; 65(3):339-44. PubMed ID: 462584
[TBL] [Abstract][Full Text] [Related]
18. Therapy for gastrointestinal cancer with the nitrosoureas alone and in drug combination.
Moertel CG; Schutt AJ; Reitemeier RJ; Hahn RG
Cancer Treat Rep; 1976 Jun; 60(6):729-32. PubMed ID: 954012
[No Abstract] [Full Text] [Related]
19. Sequential and combination chemotherapy of advanced gastric cancer.
Moertel CG; Mittelman JA; Bakemeier RF; Engstrom P; Hanley J
Cancer; 1976 Aug; 38(2):678-82. PubMed ID: 788891
[TBL] [Abstract][Full Text] [Related]
20. Phase II study of vinblastine, methyl-CCNU, and medroxyprogesterone in advanced renal cell cancer.
Hahn RG; Temkin NR; Savlov ED; Perlia C; Wampler GL; Horton J; Marsh J; Carbone PP
Cancer Treat Rep; 1978 Jul; 62(7):1093-5. PubMed ID: 356971
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
